Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00398216 · ClinicalTrials.gov registry record · Phase 2

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

A Phase 2 study of Thrombosis and Hip Replacement, sponsored by Daiichi Sankyo.

Completed
Registry status
Phase 2
Development phase
903
Enrollment target
20
Study locations

NCT00398216 is a Phase 2 study of Thrombosis and Hip Replacement that has completed, run by Daiichi Sankyo. The registered enrollment target is 903 participants, above the 438-participant average among 28 other Thrombosis trials with a reported enrollment target (106% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00398216, a Phase 2 study of Thrombosis and Hip Replacement, has completed, sponsored by Daiichi Sankyo.

COMPLETED
Registry status
Phase 2
Development phase
903 participants
Enrollment target
20
Study locations

Study Summary

This study is to assess if DU176b is effective in prevention of blood clots following hip replacement surgery. The duration is 7-10 days of treatment and 30 and 60 day follow-up visits.

Conditions Studied

Thrombosis Hip Replacement

Interventions

  • DRUG DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

Study Locations (20)

Other

  • - Hellerup
  • - Herlev
  • - Hørsholm
  • - Gyula
  • - Kecskemét
  • - Szeged
  • - Riga
  • - Krasnoyarsk
  • - Moscow
  • - Saint Petersburg
  • - Saratov
  • - Veliky Novgorod

Ontario

  • - Ajax
  • - Cambridge
  • - Guelph
  • - Kitchner
  • - Toronto

Connecticut

  • - Hartford

Florida

  • - Sarasota

Texas

  • - Austin

Trial Details

FieldValue
Enrollment Target 903 participants
Start Date 2006-05
Est. Completion 2007-06
Phase Phase 2

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00398216

The ClinicalTrials.gov registry entry for NCT00398216 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 903 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 28 other Thrombosis trials with a reported enrollment target (106% higher). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor is the first listed.

NCT00398216 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Other, Ontario, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00398216 about?

NCT00398216 is a clinical study titled "A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery". This study is to assess if DU176b is effective in prevention of blood clots following hip replacement surgery. The duration is 7-10 days of treatment and 30 and 60 day follow-up visits.

What is the current status of trial NCT00398216?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 903 participants. The study started on 2006-05. Estimated completion is 2007-06.

What conditions does trial NCT00398216 study?

This clinical trial studies the following conditions: Thrombosis, Hip Replacement.

What interventions are being tested in trial NCT00398216?

The interventions under investigation include: DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor (DRUG).

Who is sponsoring clinical trial NCT00398216?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00398216 being conducted?

This trial has 20 study locations across Connecticut, Florida, Texas, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Thrombosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Thrombosis

All registered trials for this condition

Hip Replacement

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.